SCHEMBL6922357

SCHEMBL6922357

C[C@@H]1CCC2Cn3c(nc4cc(C#Cc5cccc(F)c5)ccc4c3=O)CN2C1

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 19/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6922907 0.87 GRM5 (0.45) GRM5
SCHEMBL15865811 0.87 GRM5 (0.45) GRM5
SCHEMBL6922582 0.86 GRM5 (0.47) GRM5
SCHEMBL6922278 0.83 GRM5 (0.41) GRM5
SCHEMBL6922848 0.82 GRM5 (0.42) GRM5
SCHEMBL6921584 0.79 GRM5 (0.42) GRM5
SCHEMBL6923279 0.78 GRM5 (0.41) GRM5
SCHEMBL6920768 0.78 GRM5 (0.42) GRM5
SCHEMBL6920971 0.77 GRM5 (0.39) GRM5
SCHEMBL6920618 0.77 CHRM5 (0.40) GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075699-A2 COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2011-06-23 WO disclosed